Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes .1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines

被引:102
作者
Rondu, F
LeBihan, G
Wang, X
Lamouri, A
Touboul, E
Dive, G
Bellahsene, T
Pfeiffer, B
Renard, P
GuardiolaLemaitre, B
Manechez, D
Penicaud, L
Ktorza, A
Godfroid, JJ
机构
[1] UNIV PARIS 07,CNRS,URA 307,LAB PHARMACOCHIM MOL,F-75251 PARIS,FRANCE
[2] UNIV PARIS 07,CNRS,URA 307,LAB PHYSIOPATHOL NUTR,F-75251 PARIS,FRANCE
[3] ADIR,F-92415 COURBEVOIE,FRANCE
[4] INST RECH INT SERVIER,F-92415 COURBEVOIE,FRANCE
[5] UNIV LIEGE,INST CHIM,CTR INGN PROT,LIEGE,BELGIUM
[6] UNIV TOULOUSE 3,CNRS,UPRESA 5018,F-31062 TOULOUSE,FRANCE
关键词
D O I
10.1021/jm9608624
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The physiopathology of non-insulin-dependent diabetes mellitus is associated with a dysfunction in the regulation of insulin secretion. The alpha(2)-adrenoceptors have been reported to be involved in this alteration, although at-antagonists containing an imidazoline ring may stimulate insulin secretion independently of alpha(2)-adrenoceptor blockage. Recently, a new ''imidazoline-binding site'' involved in the control of K+-ATP channels in the B cell has been proposed. In the course of searching for new antidiabetic agents, 1-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines, 1-benzyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl) and 1-benzyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)-4-benzylpiperazines have been designed and evaluated as potential adrenoceptor antagonists. Pharmacological evaluation was performed in vivo using glucose tolerance tests performed on a rat model of type II diabetes obtained by injection of a low dose (35 mg/kg) of streptozotocin (STZ). For some compounds, binding experiments were performed on alpha(2) adrenoceptors and I-1 and I-2 imidazoline-binding sites. The biological and physicochemical data have been combined with molecular modeling studies to establish structure-activity relationships. The most active compound was 1-(2',4'-dichlorobenzyl)-2 (4',5'-dihydro-1'H-imidazol-2'-yl)-4-methylpiperazine (7f); intraperitoneal administration (100 mu mol/kg) of 7f strongly improved glucose tolerance in STZ diabetic rats. This effect seemed at least partly mediated by a significant increase of insulin secretion. Other compounds of the same family (7b, 16f, 23b) have also shown potent activity. We found no correlation between in vivo antihyperglycemic properties and in vitro affinities for alpha(2)-adrenoceptors or I-1 and I-2 binding sites. These compounds can be considered as antihyperglycemic agents potentially useful for treatment of type II diabetes and are currently under complementary investigation.
引用
收藏
页码:3793 / 3803
页数:11
相关论文
共 40 条
  • [1] IS IMIDAZOLINE SITE A UNIQUE RECEPTOR - A CORRELATION WITH CLONIDINE-DISPLACING SUBSTANCE ACTIVITY
    ATLAS, D
    DIAMANT, S
    ZONNENSCHEIN, R
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (04) : S83 - S90
  • [2] TREATMENT METFORMIN
    BAILEY, CJ
    NATTRASS, M
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1988, 2 (02): : 455 - 476
  • [3] Berger W, 1986, Journ Annu Diabetol Hotel Dieu, P243
  • [4] COMPARISON OF THE EFFECTS OF EFAROXAN AND GLIBENCLAMIDE ON PLASMA-GLUCOSE AND INSULIN LEVELS IN RATS
    BERRIDGE, TL
    DOXEY, JC
    ROACH, AG
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (02) : 213 - 218
  • [5] STIMULATION OF INSULIN-SECRETION BY IMIDAZOLINE COMPOUNDS IS NOT DUE TO INTERACTION WITH NON-ADRENOCEPTOR IDAZOXAN BINDING-SITES
    BROWN, CA
    LOWETH, AC
    SMITH, SA
    MORGAN, NG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) : 312 - 317
  • [6] CAMPBELL IW, 1990, SULPHONYLUREAS METFO, P33
  • [7] EFFECTS OF ALPHA-ADRENERGIC ANTAGONISTS ON INSULIN-SECRETION FROM RAT PANCREATIC-ISLETS
    CHAN, SLF
    HURST, RD
    MORGAN, NG
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1988, 16 (06) : 1005 - 1006
  • [8] THE ALPHA-2-ADRENOCEPTOR ANTAGONIST EFAROXAN MODULATES K+ATP CHANNELS IN INSULIN-SECRETING CELLS
    CHAN, SLF
    DUNNE, MJ
    STILLINGS, MR
    MORGAN, NG
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 204 (01) : 41 - 48
  • [9] MECHANISMS INVOLVED IN STIMULATION OF INSULIN-SECRETION BY THE HYPOGLYCEMIC ALPHA-ADRENERGIC ANTAGONIST, DG-5128
    CHAN, SLF
    STILLINGS, MR
    MORGAN, NG
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (03) : 1545 - 1551
  • [10] STIMULATION OF INSULIN-SECRETION BY THE IMIDAZOLINE ALPHA-2-ADRENOCEPTOR ANTAGONIST EFAROXAN IS MEDIATED BY A NOVEL, STEREOSELECTIVE, BINDING-SITE
    CHAN, SLF
    BROWN, CA
    MORGAN, NG
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 230 (03) : 375 - 378